AZ-9814

N/A

Report date: 2025/01/26 18:14:15
NME

Base Information

Drug NameAZ-9814
Drug Alias NameEg5 inhibitor (AstraZeneca)AZ-9814
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKinesin-like protein 1 inhibitors
TargetsKinesin-like protein 1
Therapy Area/IndicationsCarcinoma, Transitional Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca Plc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Transitional Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A